- Additional Proxy Soliciting Materials (definitive) (DEFA14A)
March 19 2010 - 4:08PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC. 20549
SCHEDULE
14A
(Rule
14A-101)
INFORMATION
REQUIRED IN PROXY STATEMENT
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of
the
Securities Exchange Act of 1934
Filed by the Registrant x
Filed by a Party other than the Registrant
Check the
appropriate box:
o
|
|
Preliminary Proxy Statement
|
o
|
|
Confidential, for Use of the
Commission Only
|
o
|
|
Definitive Proxy Statement
|
|
|
(as
permitted by Rule 14a-6(e)(2))
|
x
|
|
Definitive Additional
Materials
|
|
|
|
o
|
|
Soliciting Material Pursuant to
Rule 14a-11(c)
or Rule 14a-12
|
|
|
|
LEXICON
PHARMACEUTICALS, INC.
|
(
Name
o
f
Registrant
as Specified In Its Charter)
|
|
(Name of
Person(s) Filing Proxy Statement, if Other Than the
Registrant)
|
Payment of
Filing Fee (Check the appropriate box):
o
|
Fee
computed
on
table
below per Exchange Act
Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title
of each class of securities to which transaction
applies: N/A
|
|
(2)
|
Aggregate
number of securities to which transaction
applies: N/A
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was
determined): N/A
|
|
(4)
|
Proposed
maximum aggregate value of transaction: N/A
|
|
(5)
|
Total
fee paid: $0
|
o
|
Fee paid previously with
preliminary materials: N/A
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date
Filed
|
***
Exercise Your
Right
to Vote
***
IMPORTANT NOTICE
Regarding the
Availability of Proxy Materials
|
|
|
|
|
|
|
|
|
|
|
Meeting
Information
|
|
|
|
|
|
Meeting
Type:
Annual Meeting
|
LEXICON
PHARMACEUTICALS, INC.
|
|
For holders as of:
March 01,
2010
|
|
|
Date:
April 29,
2010
|
Time:
8:00 AM
CDT
|
|
|
Location:
|
Lexicon
Pharmaceuticals, Inc.
|
|
|
|
8800 Technology Forest
Place
|
|
|
|
The
Woodlands, TX
|
|
|
|
|
|
|
|
|
|
|
|
|
|
You
are receiving
this
communication because you hold shares in the
above named
company
.
|
|
|
|
|
|
LEXICON
PHARMACEUTICALS, INC
8800 TECHNOLOGY FOREST
PLACE
THE WOODLANDS, TX
77381-4287
|
|
|
This is not a ballot.
You cannot use this notice to vote these shares. This communication
presents only an overview of the more complete proxy materials that are
available to you on the Internet. You may view the proxy materials
online at
www.proxyvote.com
or
easily request a paper copy (see reverse side)
|
|
|
|
|
|
|
|
We
encourage you to access and review all of the important information
contained in the proxy materials before voting.
|
|
|
|
|
|
|
|
See the reverse side of this notice
to obtain proxy materials and voting
instructions.
|
|
|
|
|
—
BEFORE
YOU VOTE
—
|
How
to Access the Proxy Materials
|
|
|
|
Proxy
Materials Available to VIEW or RECEIVE:
|
|
|
1.
Notice & Proxy Statement
|
2.
Annual Report
|
|
|
How to View
Online:
|
|
|
Have the 12-Digit Control
Number available (located on the following page) and visit:
www.proxyvote.com
|
|
|
How to
Request and Receive a PAPER or E-MAIL Copy:
|
|
|
If
you want to receive a paper or e-mail copy of these documents, you must
request one. There is NO charge for requesting a copy. Please choose one
of the following methods to make your request:
|
|
|
|
1) BY
INTERNET:
|
www.proxyvote.com
|
|
|
|
2) BY
TELEPHONE:
|
1-800-579-1639
|
|
|
|
3) BY
EMAIL*:
|
sendmaterials@proxyvote.com
|
|
|
*
If requesting materials by e-mail, please send a blank e-mail with the
12-Digit Control Number (located on the following page) in the subject
line.
|
|
|
Requests, instructions and
other inquiries sent to this e-mail address will NOT be forwarded to your
investment advisor. Please make the request as instructed above on or
before April 15, 2010 to facilitate timely delivery.
|
|
|
|
|
—
HOW
TO VOTE
—
|
Please Choose One of The Following Voting
Methods
|
Vote in Person:
Many shareholder
meetings have attendance requirements including, but not limited to, the
possession of an attendance ticket issued by the entity holding the
meeting. Please check the meeting materials for any special
requirements for meeting attendance. At the Meeting you will need to
request a ballot to vote these shares.
|
|
Vote by Internet:
To vote
now
by Internet, go to
www.proxyvote.com
.
Have the 12 Digit Control Number available and follow the
instructions.
|
|
Vote
by Mail:
You can vote by mail by
requesting a paper copy of the materials, which will include a proxy
card.
|
The
Board of Directors recommends that you vote FOR the
following.
Nominees:
|
01)
Raymond Debbane
|
02)
Robert J. Lefkowitz, MD
|
03) Alan
S. Nies, MD
|
|
The Board of
Directors recommneds you vote FOR the following proposal(s):
4.
|
Ratification and approval of
the appointment of Ernst & Young LLP as the Company's independent
auditors for the fiscal year ending December 31,
2010.
|
NOTE:
In their discretion, upon such
other matters that may properly come before the meeting or any adjournment or
adjournments thereof.
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024